CELU celularity.com: Multiplikator Forward P/S
Celularity Inc. management is currently adapting its cellular platform for full-scale commercialization and monetization of biomaterials. Production stability is ensured by proprietary plants and cryostorage facilities in New Jersey featuring strict sterile control. Placenta-based tissue regeneration technology creates potential for pricing power. The forward P/S trend reflects market expectations, where 1.10 represents the latest metric reading.
Rincian metrik lan analitis perusahaan celularity.com (CELU)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- data tingkat utang lan likuiditas finansial:
Rasio Total Utang marang Ekuitas Celularity Inc.|CELU - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Celularity|CELU - Utang perusahaan|Utang-utang marang kapitalisasi buku Celularity Inc.|CELU - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Celularity|Rasio cepet celularity.com
- rincian asil keuangan lan kelipatan valuasi:
CELU - Asil keuangan resik|Bathi mangsa ngarep Celularity Inc.|CELU - Rasio rega pasar marang bathi resik|Prakiraan rega marang bathi Celularity|CELU - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Celularity Inc.|CELU - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Celularity|CELU - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan celularity.com|CELU - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Celularity Inc.
- rincian pendapatan lan dodolan:
Ringkesan analitik perusahaan:Celularity Corp CELU
The business resilience of Celularity Inc. (CELU) depends on the commercialization of placental therapy and the sale of biomaterials for regenerative medicine. The projected P/S dynamics correlate the company's current market value with expected revenue, accounting for the impact of interest rates on the cost of capital. An increase in this ratio signals inflated market expectations, which raises the risk of a price correction toward a fair value level.
Pesaing Celularity Inc.
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Abivax Corp - Multiplikator Forward P/S|ADMA Corp (ADMA) - Multiplikator forward rega marang pendapatan|PTGX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep immunovant.com (IMVT)|Rasio rega marang prakiraan pendapatan Kiniksa|Rasio rega marang prakiraan pendapatan GRFS|Multiplikator forward rega marang pendapatan ADPT (Adaptive Biotechnologies Corp)|Multiplikator Forward P/S Celldex Corp (CLDX)|Rasio rega marang prakiraan pendapatan Aurinia Pharmaceuticals AUPH|biocryst.com - Rasio rega marang prakiraan pendapatan|Vera Therapeutics - Multiplikator Forward P/S|DNTH - Multiplikator Forward P/S|Pharvaris Corp (PHVS) - Rasio rega marang prakiraan pendapatan|AbCellera Corp - Rega forward marang dodolan|TRML (Tourmaline Bio, Inc.) - Multiplikator Forward P/S|precigen.com (PGEN) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan PHAR (Pharming Group)|Rasio rega marang pendapatan sing dikarepake NKTR|Upstream Bio Corp - Multiplikator forward rega marang pendapatan|Zenas Corp (ZBIO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|IMNM: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan GOSS (gossamerbio.com)|KALV: Multiplikator Forward P/S|SEPN - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Pieris Pharmaceuticals Inc|Kapitalisasi marang prakiraan pendapatan SVRA (Savara Pharma)|Multiplikator Forward P/S RIGL|Multiplikator forward rega marang pendapatan anaptysbio.com ANAB|Astria Therapeutics, Inc. - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake enGene Holdings Inc (ENGN)|RAPT Therapeutics, Inc. - Multiplikator Forward P/S|Aerovate Therapeutics Inc (JBIO) - Multiplikator forward rega marang pendapatan|ACRS: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep kyvernatx.com (KYTX)|Rasio rega marang prakiraan pendapatan Tiziana Life Sciences Ltd|Rasio rega marang prakiraan pendapatan CABA|Multiplikator forward rega marang pendapatan VTYX (Ventyx Bio)|Multiplikator Forward P/S Theratechnologies, Inc (THTX)|Rasio rega marang prakiraan pendapatan Avalo Therapeutics, Inc AVTX|ELDN (eledon.com) - Rega mangsa ngarep marang pendapatan|Agenus Inc. - Multiplikator Forward P/S|Rega forward marang dodolan CLYM (Climb Bio Inc.)|ZURA: Multiplikator Forward P/S|aTyr Pharmaceuticals (ATYR) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Adagene Inc|IMA: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Shattuck Labs, Inc. (STTK)|Multiplikator forward rega marang pendapatan equilliumbio.com EQ|Multiplikator Forward P/S CNTB (Connect Biopharma Holdings Limited)|Multiplikator Forward P/S Immunic Therapeutics IMUX|ATRA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan IFRX (InflaRx N.V.)|XFOR: Multiplikator Forward P/S|ACET - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan INmune Bio Corp|Multiplikator forward rega marang pendapatan Barinthus Biotherapeutics Corp (BRNS)|Rasio rega marang prakiraan pendapatan Kezar Life Sciences (KZR)|Multiplikator forward rega marang pendapatan sabbiotherapeutics.com SABS|Akari Therapeutics Plc - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Enlivex Therapeutics Ltd ENLV|QTTB - Rasio rega marang prakiraan pendapatan|GOVX (GeoVax Corp) - Kapitalisasi marang prakiraan pendapatan|EDSA: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ibioinc.com (IBIO)|CARM (Carisma Therapeutics Inc) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan XTL Biopharmaceuticals Ltd (XTLB)|Multiplikator Forward P/S BOLT|HCWB - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Aptevo Therapeutics Inc. APVO|AIM ImmunoTech, Inc. - Rasio rega marang prakiraan pendapatan|ADTX: Multiplikator forward rega marang pendapatan|GRI - Multiplikator Forward P/S|XORTX (XRTX) - Rasio rega marang prakiraan pendapatan|HIND (Vyome Therapeutics) - Rasio rega marang prakiraan pendapatan|REVB (Revelation Biosciences) - Multiplikator Forward P/S|Multiplikator Forward P/S indaptusrx.com|Rasio rega marang prakiraan pendapatan Scinai Immunotherapeutics Ltd. (SCNI)|CALI (calcimedica.com) - Rega forward marang dodolan|Multiplikator Forward P/S AFMD (Affimed N.V.)|Rasio kapitalisasi marang dodolan sing dikarepake Allakos Inc (ALLK)|HOOK: Multiplikator forward rega marang pendapatan|IGM Biosciences, Inc. - Rasio rega marang pendapatan sing dikarepake|ITOS (iTeos Therapeutics, Inc.) - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Ocean Biomedical Inc (OCEA)|Multiplikator forward rega marang pendapatan TCBP|THRD: Rega forward marang dodolan
